Document is current
Any future updates will be listed below
-
Authors
Sevenich, Marc https://orcid.org/0000-0002-7036-6927
Gering, Ian
Kass, Bettina
Vollmer, Madita
Aghabashlou Saisan, Selma
Tusche, Markus
Kupreichyk, Tatsiana https://orcid.org/0000-0002-5151-6424
Pauly, Thomas
Stoldt, Matthias
Hoyer, Wolfgang https://orcid.org/0000-0003-4301-5416
Willuweit, Antje https://orcid.org/0000-0002-6725-0755
Kutzsche, Janine https://orcid.org/0000-0003-0271-7390
Lakomek, Nils-Alexander
Nagel-Steger, Luitgard
Gremer, Lothar https://orcid.org/0000-0001-7065-5027
Tamgüney, Gültekin
Mohrlüder, Jeannine
Willbold, Dieter
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (MJFF-000934, MJFF-000934, MJFF-000934, MJFF-000934, MJFF-000934, MJFF-000934, MJFF-000934)
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 6 August 2025
First Online: 22 September 2025
Competing interests
: M.S., J.M., and D.W. are co-inventors of patents covering the composition of matter of SVD-peptides. D.W. and A.W. are co-founders and shareholders of the company “Priavoid GmbH, Düsseldorf, Germany”, which is planning to further develop the SVD-peptides. M.S., B.K., and A.W. are employees of Priavoid GmbH. They declare that this has not influenced the evaluation and interpretation of experiments. All other authors declare no competing interests.
